Langerhans cell histiocytosis (LCH) carries a prognosis, which ranges from benign to potentially fatal. There is currently little framework to decipher metrics, which predict the benign versus aggressive nature of LCH. We wanted to determine whether molluscum contagiosum virus (MCV) DNA could be isolated from a cutaneous lesion, demonstrating Langerhans cell hyperplasia resembling LCH in a patient with both. Polymerase chain reaction on biopsy-proven MCV and the hyperplastic lesion has been performed. Two specific regions within the MCV genome were detected from both biopsies. The authors report our findings and suggest that some MCV can produce histological lesions resembling LCH, similar to the literature on scabies mimicking LCH. Efforts to find a reactive "driver" in LCH may significantly inform the clinical scenario.
CASE REPORT
A 14-year-old white boy initially presented to the pediatric dermatology clinic with 4 umbilicated papules located on his abdomen, right chest, and right arm. His medical history and review of systems was unremarkable. A clinical diagnosis of molluscum contagiosum was made. After discussing the pathophysiology and risks, benefits, and alternatives to therapy, treatment was deferred on this initial visit. Six months later, the patient returned with a persistent lesion on his lower abdomen. The patient and his mother report that since his last visit, the other papules had resolved and that he had "a few more" develop that had since resolved. This persistent papule was on his lower abdomen and had become pruritic.
Physical examination found a well-developed healthy appearing young man. He had 2-4 mm shallow pockmarks on his chest and arm consistent with resolved molluscum contagiosum. On his right lower abdomen was a 7 mm, erythematous, umbilicated papule. A shave biopsy of this lesion was performed.
Microscopic examination (Figs. 1, A-C) revealed a specimen with a well circumscribed dense infiltrate of epithelioid cells with reniform nuclei, which stained strongly with antibodies against S100 and CD1a (Fig. 1D ). These cells did not stain with antibodies against AE1/AE3, EMA, or CD68, although there were relatively few scattered CD68-positive histiocytes in the surrounding area. A rare number of eosinophils were found in the sections examined. The epidermis overlying the tumor showed compact parakeratosis with moderate diminution of the granular layer and loss of rete pegs. The diagnosis was consistent with CD1a + Langerhans cell histiocytosis (LCH). There was no histological evidence of MCV in this specimen on deeper sections.
Upon follow-up for excision of the solitary cutaneous LCH, a new umbilicated papule had formed on his right forearm. The excision on his abdomen of the LCH lesion was performed, and a shave biopsy on his right forearm was taken. The biopsy was consistent with molluscum contagiosum (Figs. 1E, F).
Given the almost identical clinical appearance of the lesions and with a concurrent diagnosis of biopsy-proven molluscum contagiosum, we decided to perform PCR on all 3 specimens for molluscum contagiosum virus (MCV) DNA-the initial biopsy of LCH, the excised LCH, and the biopsy of molluscum contagiosum. Polymerase chain reaction (PCR) was performed, as previously published, 1 to amplify 2 distinct portions of the MCV genome. We amplified MCV DNA within both the MCV biopsy, which was expected, as well as from the initial biopsy of LCH ( Fig. 2A ). No bands were detected from the LCH excision specimen.
These are the first results demonstrating MCV DNA within a cutaneous lesion of hyperplastic Langerhans cells (LC), which was clinically identical to a molluscum papule and in a patient who concurrently had clinically and histologically confirmed molluscum contagiosum. Our findings suggest, at least in this case, that CD1a + Langerhans cell collections can be reactive to or induced by MCV as opposed to intrinsic oncogenic mutations.
MATERIALS AND METHODS
The skin punch biopsy was fixed in 10% neutralbuffered formalin, processed and embedded in paraffin. The paraffin-embedded tissue was cut into 5-mm thick sections and stained with hematoxylin and eosin. Immunohistochemistry was performed using the following Dako LSAB2 kit. Retrieval was performed for EMA, CD68, AE1/AE3, CD1a, and S100 retrieval solution for 20 minutes, followed by peroxidase for 10 minutes. For AE1/AE3, the same retrieval was followed by 50 mL of proteinase K and 450 mL of dilution:incubation for 6 minutes. Dilution:incubation time were as follows: S100 (1:1000: 20 minutes), CD1a (1:100: 10 minutes), AE1/AE3 (1:50: 10 minutes), EMA (1:50: 30 minutes), and CD68 (1:50: 10 minutes). Antibody for EMA is 30 minutes and for S100, CD68, Cd1a, and AE1/AE3 is 10 minutes. Yellow link is then applied for 10 minutes, then red link for 10 minutes, followed by 3, 3 0 -Diaminobenzidine (DAB) application.
PCR for MCV genome was performed with modifications from the protocol by Saral et al. 2 In brief, DNA was extracted from formalin-fixed paraffin-embedded tissue using a Qiagen DNeasy kit. The following primers were used to amplify MCV genome: F1 (5 0 -GGCGCGTAGCCGAGCGG-3 0 ) and R1 (5 0 -GCTTCCGGGCTTGCCGCCGGGCAG-3 0 ) primers amplify a 393-base pair (bp) portion of gene encoding p43K; KU (5 0 -GGAGGAGTGCCCATCAAGAAT-3 0 ) and OR (5 0 -GCTTTTCAGTTTTTGTGCGA-3 0 ) primers amplify a 575-bp product from the gene encoding p43K. DNA was amplified and samples were run on a 1.5% agarose gel after 40 cycles. DMSO was used to alter binding properties to allow detection of the 575-bp product in the sample.
DISCUSSION
Reactive or neoplastic, the debate endures regarding LCH. LCH is a rare disease consisting of mixed cellularity granulomas containing Langerhans cell-like CD1a + and CD207 + (langerin + ) histiocytes and runs a variable course from benign solitary tumors to fatal multiorgan disease. Historically, the definitive diagnosis of LCH was established by the appropriate morphological appearance of histiocytes that had Birbeck granules or stained positively with antibodies for either CD1a or CD207. Yet, not all tumors, having met the accepted diagnostic criteria, behave in a consistent predictable fashion. Thus, the debate whether LCH represents a reactive process or true oncogenesis continues to be studied. The clearly benign nature of many cases would favor a reactive process, whereas recent discoveries of specific BRAF mutations in some cases of LCH would favor mutation-driven oncogenic transformation. Badalian-Very et al identified the oncogenic BRAF V600E mutation in 35 of the 61 LCH tumors they sampled, which would suggest true neoplasia, at least in some cases. 3 But, how do these "epidermal-resident" CD207 + LC cause multiorgan disease? Through cell-specific gene expression studies, it has been proposed that pathological LC in LCH derive from bone marrow-derived myeloid dendritic cell precursors and migrate to sites of LCH, suggesting that CD207 (langerin) is inducible from a bone marrow source. 4 Other analyses of LCH being associated with viral infections such as Epstein-Barr virus, cytomegalovirus, and other human herpes viruses have borne out mixed results. [5] [6] [7] [8] Supporting a potential reactive etiology for LCH, numerous cases of benign Langerhans cell hyperplasia have been reported with scabies infestation. [9] [10] [11] Distinguishing between reactive versus intrinsic neoplastic mechanisms is important, as the first scenario is self-limited in contrast to the latter, which has a relatively poor prognosis and requires systemic chemotherapy. Although there are no reported cases of LCH associated with molluscum contagiosum to date, we found 3 case reports of patients with molluscum-like papules ultimately diagnosed as having LCH. 1, 12, 13 We report our findings in a patient with concurrent solitary cutaneous hyperplasia of LC and molluscum confirmed clinically, histologically, and by PCR. We identified MCV DNA in the lesion of LCH but not adjacent healthy skin from excision Burow triangles. This effort to find a reactive driver using a more sensitive PCR technique supports a reactive and benign course in the absence of other histological evidence.
Similar reports of Langerhans cell hyperplasia, histologically identical to LCH, are well established for scabies. We propose that similar findings of Langerhans cell hyperplasia, indistinguishable from LCH, may occur secondary to molluscum contagiosum. Similarly, clinical lesions of LCH have been reported to resemble molluscum. The presence and potential role of MCV in LCH. A, PCR amplification of MCV in the presence of DMSO free and 1% DMSO buffer. DNA was harvested from 3 different samples: "A" was taken from the right forearm, biopsy consistent with molluscum contagiosum; "B" was taken from the lower abdomen, reexcision of biopsy site; and "C" was taken from the lower abdomen, biopsy consistent with Langerhans cell histiocytosis or hyperplasia. Two different primer pairs, ku+ or (a) and f1 + f2 (b), were used to amplify 2 distinct portions of the MCV genome. The sizes of the expected fragments are 393 and 575 bp. DMSO was added to allow detection of MCV from the lower abdomen biopsy. B, Model of Langerhans cell proliferation driven by MCV infection. In our case, a papule clinically consistent with molluscum contagiosum (clinical photograph of patient shown) was histologically striking for the expansion of Langerhans cells.
